No Clinical Benefit of Empirical Antimicrobial Therapy for Pediatric Diarrhea in a High-Usage, High-Resistance Setting | Zendy

Vu Thuy Duong | Zendy; Ha Thanh Tuyen | Zendy; Pham Van Minh | Zendy; James I. Campbell | Zendy; Hoang Le Phuc | Zendy; Tran Do Hoang Nhu | Zendy; Le Thi Phuong Tu | Zendy; Tran Thi Hong Chau | Zendy; Le Thi Quynh Nhi | Zendy; Nguyễn Thanh Hùng | Zendy; Nguyễn Minh Ngọc | Zendy; Thi Thanh Huong Nguyen | Zendy; Lu Lan | Zendy; Corinne N. Thompson | Zendy; Guy Thwaites | Zendy; Ruklanthi de Alwis | Zendy; Stephen Baker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

No Clinical Benefit of Empirical Antimicrobial Therapy for Pediatric Diarrhea in a High-Usage, High-Resistance Setting

Author(s) -

Vu Thuy Duong,

Ha Thanh Tuyen,

Pham Van Minh,

James I. Campbell,

Hoang Le Phuc,

Tran Do Hoang Nhu,

Le Thi Phuong Tu,

Tran Thi Hong Chau,

Le Thi Quynh Nhi,

Nguyễn Thanh Hùng,

Nguyễn Minh Ngọc,

Thi Thanh Huong Nguyen,

Lu Lan,

Corinne N. Thompson,

Guy Thwaites,

Ruklanthi de Alwis,

Stephen Baker

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix844

Subject(s) - medicine , antimicrobial , diarrhea , campylobacter , interquartile range , antibiotic resistance , shigella , intensive care medicine , salmonella , antibiotics , microbiology and biotechnology , biology , genetics , bacteria

Pediatric diarrheal disease presents a major public health burden in low- to middle-income countries. The clinical benefits of empirical antimicrobial treatment for diarrhea are unclear in settings that lack reliable diagnostics and have high antimicrobial resistance (AMR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research